Hui, E P <br/><br/>
Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  06 2020 
 - 769-779 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1016/j.annonc.2020.03.289  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>DNA, Viral--genetics<br/>Epstein-Barr Virus Infections--pathology<br/>Herpesvirus 4, Human--genetics<br/>Humans<br/>Nasopharyngeal Carcinoma--therapy<br/>Nasopharyngeal Neoplasms--radiotherapy<br/>Neoplasm Recurrence, Local<br/>Neoplasm Staging<br/>Plasma<br/>Prognosis<br/>Prospective Studies<br/>Retrospective Studies<br/>Risk Assessment